000 | 01964 a2200553 4500 | ||
---|---|---|---|
005 | 20250516165300.0 | ||
264 | 0 | _c20140512 | |
008 | 201405s 0 0 eng d | ||
022 | _a1940-6215 | ||
024 | 7 |
_a10.1158/1940-6207.CAPR-13-0185 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLashinger, Laura M | |
245 | 0 | 0 |
_aDietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth factor-I. _h[electronic resource] |
260 |
_bCancer prevention research (Philadelphia, Pa.) _cOct 2013 |
||
300 |
_a1046-55 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 | _aBody Composition |
650 | 0 | 4 | _aCaloric Restriction |
650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p16 _xgenetics |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aEnergy Metabolism |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
650 | 0 | 4 |
_aLiver _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aObesity _xcomplications |
650 | 0 | 4 |
_aPancreatic Neoplasms _xcomplications |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aProto-Oncogene Proteins p21(ras) _xgenetics |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aHarrison, Lauren M | |
700 | 1 | _aRasmussen, Audrey J | |
700 | 1 | _aLogsdon, Craig D | |
700 | 1 | _aFischer, Susan M | |
700 | 1 | _aMcArthur, Mark J | |
700 | 1 | _aHursting, Stephen D | |
773 | 0 |
_tCancer prevention research (Philadelphia, Pa.) _gvol. 6 _gno. 10 _gp. 1046-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1940-6207.CAPR-13-0185 _zAvailable from publisher's website |
999 |
_c23036265 _d23036265 |